Simplex Trading
MRVI icon

Simplex Trading’s Maravai LifeSciences MRVI Stock Holding History

Simplex Trading’s Portfolio MRVI Stock Details MRVI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$64.5K Buy
+22,800
New +$77.3K ﹤0.01% 5581
2025
Q4 		– Sell
-8,700
Closed -$24K – 9501
2025
Q3 		$24K Sell
8,700
-8,000
-48% -$20.4K ﹤0.01% 7184
2025
Q2 		$40K Sell
16,700
-1,100
-6% -$2.31K ﹤0.01% 6147
2025
Q1 		$39K Buy
17,800
+9,000
+102% +$35.6K ﹤0.01% 6029
2024
Q4 		$47K Sell
8,800
-300
-3% -$1.93K ﹤0.01% 5931
2024
Q3 		$75K Sell
9,100
-5,900
-39% -$51K ﹤0.01% 5508
2024
Q2 		$107K Sell
15,000
-19,900
-57% -$172K ﹤0.01% 5315
2024
Q1 		$302K Sell
34,900
-42,100
-55% -$285K ﹤0.01% 4389
2023
Q4 		$504K Buy
77,000
+72,100
+1,471% +$466K ﹤0.01% 3695
2023
Q3 		$49K Sell
4,900
-286,400
-98% -$3.14M ﹤0.01% 5824
2023
Q2 		$3.62M Buy
291,300
+283,000
+3,410% +$3.82M ﹤0.01% 1532
2023
Q1 		$116K Buy
8,300
+7,400
+822% +$106K ﹤0.01% 4991
2022
Q4 		$12K Buy
900
+100
+13% +$1.57K ﹤0.01% 7375
2022
Q3 		$20K Sell
800
-2,100
-72% -$52.7K ﹤0.01% 7529
2022
Q2 		$82K Sell
2,900
-3,100
-52% -$98.2K ﹤0.01% 5825
2022
Q1 		$211K Buy
6,000
+3,600
+150% +$121K ﹤0.01% 5082
2021
Q4 		$100K Sell
2,400
-1,800
-43% -$72.9K ﹤0.01% 6250
2021
Q3 		$168K Buy
4,200
+3,300
+367% +$161K ﹤0.01% 5869
2021
Q2 		$37K Buy
900
+816
+971% +$31.6K ﹤0.01% 8002
2021
Q1 		$299K Buy
+84
New +$2.78K ﹤0.01% 4147

Other funds holding MRVI

GL
GTCR LLC Chicago, Illinois $3.78B AUM 27.82% 1-Year Est. Return
B
Braidwell Stamford, Connecticut $3B AUM 46.72% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
1WCM
12 West Capital Management New York $592M AUM 40.75% 1-Year Est. Return
Mackenzie Financial
Mackenzie Financial Toronto Ontario, Ontario, Canada $83.3B AUM 31.19% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
TC
Tejara Capital London, United Kingdom $303M AUM 5.43% 1-Year Est. Return
MAM
Monaco Asset Management Monaco $542M AUM 54.4% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Simplex Trading's MRVI Position: Q2 2024 in Review

Simplex Trading sold out of Maravai LifeSciences (MRVI) in Q2 2024, closing a stake of 14,764 shares — an estimated $127K sold.

Simplex Trading first reported a position in MRVI in Q1 2021 and held it in 12 quarters. The position peaked at $1.87M in Q2 2023. 206 funds tracked by Wall St. Rank hold MRVI as of Q2 2024.

  • Simplex Trading reported no remaining Maravai LifeSciences position as of Q2 2024 after selling out during the quarter.
  • Simplex Trading sold 14,764 Maravai LifeSciences shares in Q2 2024, an estimated $127K.
  • Simplex Trading first reported a position in Maravai LifeSciences in Q1 2021 and held it in 12 quarters.
  • Simplex Trading's Maravai LifeSciences position peaked at $1.87M in Q2 2023.
  • 206 funds tracked by Wall St. Rank held Maravai LifeSciences as of Q2 2024.

Based on Simplex Trading's 13F filing for Q2 2024, filed 25 Jul 2024.